The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Delivery > SkyePharma Inc.

SkyePharma Inc.
 PROFILE
SkyePharma Inc. (formerly DepoTech) provides a steady stream with its DepoFoam technology. The US subsidiary of UK-based drug-delivery company SkyePharma, it develops sustained-release therapeutic products based on DepoFoam, an injectable drug-delivery technology. DepoFoam formulations can release drugs over a few days or even several weeks. The company's lead product is DepoCyt for the treatment of cancer-related neoplastic meningitis; marketing rights are held by Chiron in the US and Paladin Labs in Canada. SkyePharma Inc. also makes DepoMorphine, a DepoFoam formulation of the painkiller.

 COMPETITION
ALZA Corporation (dossier)
Matrix Pharmaceutical, Inc. (MATX)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1999 Sales (mil.): 28.70
Employees: 354
Revenue per employee: $81,073.45

 KEY PEOPLE
• John P. Longenecker
    CEO
• Tom Zech
    CFO

 CONTACT INFO
10450 Science Center Dr.
San Diego, CA 92121
US
Phone: 858-625-2424
Fax: 858-625-2439
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001